Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BIMEKIZUMAB vs BISMUTH SUBCITRATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BIMEKIZUMAB vs BISMUTH SUBCITRATE: Safety Overview

Metric BIMEKIZUMAB BISMUTH SUBCITRATE
Total FAERS Reports 2,459 167
Deaths Reported 31 0
Death Rate 1.3% N/A
Hospitalizations 565 41
Average Patient Age 52.9 yrs 44.8 yrs
% Female Patients 59.9% 70.8%
Manufacturer UCB, Inc. H2-Pharma, LLC
Route SUBCUTANEOUS ORAL